https://www.healio.com/news/pulmonology/20230627/dupilumab-decreases-exacerbation-rate-improves-lung-function-in-copd-type-2-inflammation
0
0
6/27/23 at 12:08pm
Organization
Healio
Authors
WASHINGTON — At 52 weeks, adults with moderate/severe COPD and type 2 inflammation receiving dupilumab had a lower exacerbation rate and better lung function, according to an American Thoracic Society International Conference presentation.“Dupilum…
Create an account
or login to join the discussion